Carl Schmid has been a national policy and advocacy leader in the HIV community for over 25 years. He spent 16 years with The AIDS Institute, where he served as its Deputy Executive

Director and led the Institute’s HIV and viral hepatitis federal policy work before the executive agencies and the Congress. In January 2020, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

Mr. Schmid helps lead the HIV and hepatitis communities’ advocacy efforts in Washington, D.C., to ensure domestic HIV and hepatitis programs, including the Ending the HIV Epidemic initiative, the Ryan White Program, CDC HIV and hepatitis prevention programs, and NIH AIDS Research are based on sound public policy and fully funded. He serves on the Convening Group of the Federal AIDS Policy Partnership (FAPP) and co-chairs its AIDS Budget and Appropriations Coalition.

He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of people living with or at risk of HIV and hepatitis. Mr. Schmid works extensively with other patient and disease groups on collective efforts to ensure that patients, particularly those with chronic conditions, have access to quality and affordable healthcare, including prescription medications.

From December 2018 to August 2021, he served as Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA) and Co-Chaired its Ending the HIV Epidemic Subcommittee through June 2023. He previously served on PACHA in 2007-09 and chaired its Domestic Subcommittee.

In January 2021, Mr. Schmid was selected as a consumer representative to the National Association of Insurance Commissioners (NAIC), a post he served during 2018-19. In February 2023, Mr. Schmid was appointed to the NAIC/Consumer Participation Board of Trustees. In April 2023, he was appointed to the Leadership Advisory Council for the U.S. Business Action to End HIV, which he currently Chairs. In July 2019, he was appointed to the PEPFAR Scientific Advisory Board.

In 2010, he was named by POZ magazine as one of the 100 most effective AIDS fighters and by Whitman-Walker Health as one of the 25 individuals who have played prominent roles in the fight against HIV in D.C. In 2016, he was named the Champion of the Year by the ADAP Advocacy Association.